IMNM: Immunome, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
P/E koeffitsiyentini o'sish sur'atlari bilan solishtirish algoritmlar yallig'lanishga qarshi agentlar sintezini qanday avtomatlashtirishini ko'rsatadi, garchi yakuniy nazorat shifokorlar qo'lida qolsa-da. 0.00 qiymati ushbu metrikaning joriy hajmini ko'rsatib, ADC dori patentlarining va noyob antitelalarni ajratish usulining qiymatini ta'kidlaydi. Immunome, Inc. (IMNM) kompaniyasining investitsiyaviy jozibadorligi dori vositalarini ishlab chiqishning to'liq no-tsiklik tabiatiga asoslangan bo'lib, bu bozorlardagi beqarorlikdan qat'i nazar, aktivlar barqarorligini kafolatlaydi.
Immunome, Inc. (IMNM) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Immunome, Inc.|IMNM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi immunome.com|IMNM - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Immunome Corp|IMNM - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Immunome|Tezkor likvidlik ko‘rsatkichi immunome.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
IMNM - Kompaniyaning sof foydasi|Kelajakdagi foyda Immunome, Inc.|IMNM - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Immunome Bio|IMNM - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Immunome Corp|IMNM - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Immunome|IMNM - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi immunome.com|IMNM - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Immunome, Inc.
Kompaniyaning umumiy tahlili:IMNM - Immunome Inc
Ushbu ko'rsatkich joriy P/E koeffitsientini foyda o'sish sur'atlari bilan solishtiradi, bunda birdan past qiymat biznesning kengayishiga nisbatan fundamental past baholanganligidan dalolat beradi. O'sish aksiyalarining jozibadorlik indikatorini tahlil qilish orqali, investor bozor narxi Immunome, Inc. (IMNM) kompaniyasining o'ziga xos antitelalarni kashf qilish platformasi asosida patent himoyasidagi ADC dori vositalarini yaratish salohiyatini qanchalik past baholayotganini aniqlashi mumkin.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Pharvaris Pharma PHVS|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori tourmalinebio.com|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Narx-foyda va o‘sish multiplikatori Pharming Group NV (PHAR)|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|PEG multiplikatori Upstream Pharma (UPB)|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|GOSS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|KALV - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Septerna, Inc.|Pieris Pharmaceuticals Inc (PVLA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Savara Pharma|RIGL (Rigel Pharmaceuticals) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda anaptysbio.com ANAB|Narx-foyda va o‘sish multiplikatori ATXS (Astria Therapeutics, Inc.)|ENGN (enGene Holdings Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aerovate Therapeutics, Inc. (JBIO)|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|KYTX (kyvernatx.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|TLSA: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Cabaletta Bio Inc.|Narx-foyda va o‘sish multiplikatori VTYX|Theratechnologies, Inc (THTX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori AVTX|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati eledon.com|Narxning foydaga va o‘sish sur’atiga nisbati Agenus Inc. AGEN|CLYM - Narx-foyda va o‘sish multiplikatori|ZURA - Narxning foydaga va o‘sish sur’atiga nisbati|ATYR (aTyr Pharmaceuticals) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Ikena Oncology|Narxning foydaga va o‘sish sur’atiga nisbati Shattuck Labs Inc|Equillium Bio - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori CNTB|IMUX (immunic-therapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ATRA (Atara Bio)|PEG multiplikatori InflaRx NV IFRX|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACET (Adicet Bio)|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori INmune Bio Corporation|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|PEG multiplikatori kezarlifesciences.com|Narx-foyda va o‘sish multiplikatori SABS (SAB Biotherapeutics, Inc.)|AKTX (Akari Therapeutics PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Q32 Bio Inc (QTTB)|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|edesabiotech.com (EDSA) - Narx-foyda va o‘sish multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Carisma Therapeutics Inc.|Narx-foyda va o‘sish multiplikatori XTLB|PEG multiplikatori Bolt Bio|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|aptevotherapeutics.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori AIM (AIM ImmunoTech)|Aditxt Inc. (ADTX) - O‘sish sur’atiga tuzatilgan narx-foyda|GRI Bio Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|Narx-foyda va o‘sish multiplikatori CALI (CalciMedica, Inc.)|PEG multiplikatori affimed.com (AFMD)|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori TC BioPharm Ltd|THRD (Third Harmonic Bio) - PEG multiplikatori
